PHOENIX, Feb. 16,
2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES,
"SenesTech" or the "Company"), (www.senestech.com) the rodent
fertility control experts and inventors of the only EPA registered
contraceptive for male and female rats, ContraPest®,
today reported the appointment of Nicole
Williams as Chief Revenue Officer. Ms. Williams was
previously Chief Strategy Officer, and this appointment is part of
an expansion and restructuring of the sales organization and
commercialization efforts.
The restructuring of the team comes after yet another quarter
and fiscal year of record revenue, and will position the Company to
further focus on revenue in 2023. The Company has expanded its
field sales organization to seven (7), deployed by geography with
leadership in both the East and West. Always innovating and
improving customer service, the Company is also growing the
commercial team by bringing on an E-Commerce Manager to increase
product education, awareness, and accessibility to purchase.
"Last year's revenue was largely growth within existing
customers, which speaks to having an effective product that
delivers value," said Nicole
Williams, SenesTech's Chief Revenue Officer. "We are
starting this year with a strong regional focus on new customer
acquisition. With an expanded commercial team and new depths of
vertical industry knowledge we are getting in front of decision
makers, tightening the sales cycle, and driving revenue."
"Based on a surge of acceptance, we are re-deploying and
focusing our direct sales efforts by putting our reps closer to the
customers. Nicole will lead this team, expand the e-commerce growth
strategy, and grow revenue in key business verticals in the pest
management and other professional markets. We are focused on taking
the foundation built in 2022 and accelerating beyond the 2X growth
rate," said Joel Fruendt,
SenesTech's CEO.
The Company will be releasing its fourth quarter financials in
March, 2023.
About SenesTech
We are the experts in rat
fertility control. Our passion is to create a healthy environment
by better controlling rat pest populations. We keep an inescapable
truth in mind. Two rats and their descendants can be responsible
for the birth of up to 15,000 pups after a year. We invented
ContraPest, the only U.S. EPA registered contraceptive for
male and female rats. ContraPest fits seamlessly into
all integrated pest management programs, greatly improving the
overall goal of effective rat management. We strive for clean
cities, efficient businesses, and happy households – with a product
that was designed to be effective and sustainable without killing
rats. At SenesTech, we are committed to
improving the health of the world by humanely managing animal
populations through fertility control.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
This press release
contains "forward-looking statements" within the meaning of federal
securities laws, and we intend that such forward-looking statements
be subject to the safe harbor created thereby. Such forward-looking
statements include, among others, our belief that the restructuring
of the sales organization team will position the Company to further
focus on revenue in 2023; our belief that we are always innovating
and improving customer service; our belief that we are starting
this year with a strong regional focus on new customer acquisition;
our belief that with an expanded commercial team and new depths of
vertical industry knowledge, we are getting in front of decision
makers, tightening the sales cycle, and driving revenue; our plans,
based on a surge of acceptance, to re-deploy and focus our direct
sales efforts by putting our reps closer to the customers; our
expectation that Nicole Williams
will continue to lead the team, expand the e-commerce growth
strategy, and grow revenue in key business verticals in the pest
management and other professional markets; and our focus on taking
the foundation built in 2022 and accelerating beyond the 2X growth
rate. Forward-looking statements may describe future expectations,
plans, results or strategies and are often, but not always, made
through the use of words such as "believe," "may," "future,"
"plan," "will," "should," "expect," "anticipate," "eventually,"
"project," "estimate," "continuing," "intend" and similar words or
phrases. You are cautioned that such statements are subject to
risks, uncertainties and other factors that could cause actual
results to differ materially from those reflected by such
forward-looking statements. Such factors include, among others, the
impacts and implications of the COVID-19 pandemic, the successful
commercialization of our products, market acceptance of our
products, regulatory approval and regulation of our products and
other factors and risks identified from time to time in our filings
with the Securities and Exchange Commission, including our Annual
Report on Form 10-K for the fiscal year ended December 31, 2021, our Registration Statement on
Form S-1, filed with the Securities and Exchange Commission on
October 24, 2022, as amended on
November 15, 2022, and the final
prospectus related thereto. All forward-looking statements
contained in this press release speak only as of the date on which
they were made and are based on management's assumptions and
estimates as of such date. Except as required by law, we do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investors: Robert
Blum, Joe Dorame, Joe Diaz, Lytham
Partners,
LLC,
602-889-9700, senestech@lythampartners.com
Press: Nicole Williams, Chief
Revenue Officer, SenesTech, Inc., 928-779-4143
Company: Tom Chesterman, Chief Financial Officer,
SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-names-nicole-williams-as-chief-revenue-officer-301748173.html
SOURCE SenesTech, Inc.